Nonhuman primate model of schizophrenia using a noninvasive EEG method

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 38, 2013, Pages 15425-15430

  Gil Da Costa, Ricardo ^a   Stoner, Gene R ^a   Fung, Raynard ^a   Albright, Thomas D ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Brain; Medicine; Monkey; Neurology; Psychiatry

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; HUMAN; MALE; MISMATCH NEGATIVITY; NEUROPHYSIOLOGY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; SCHIZOPHRENIA; ADULT; ANIMAL; AUDITORY STIMULATION; BRAIN MAPPING; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

MACACA; MACACA MULATTA; PRIMATES;

ACOUSTIC STIMULATION; ADULT; ANIMALS; BRAIN MAPPING; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; HUMANS; KETAMINE; MACACA MULATTA; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84884334048     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1312264110     Document Type: Article

References (36)

1. Rissling AJ, Light GA (2010) Neurophysiological measures of sensory registration, stimulus discrimination, and selection in schizophrenia patients. Curr Top Behav Neurosci 4:283-309.
2. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148(10):1301-1308.
3. Umbricht D, et al. (2000) Ketamine-induced deficits in auditory and visual contextdependent processing in healthy volunteers: Implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57(12):1139-1147.
4. Garrido MI, Kilner JM, Kiebel SJ, Friston KJ (2007) Evoked brain responses are generated by feedback loops. Proc Natl Acad Sci USA 104(52):20961-20966.
5. Sutton S, Braren M, Zubin J, John ER (1965) Evoked-potential correlates of stimulus uncertainty. Science 150(3700):1187-1188.
6. Baribeau-Braun J, Picton TW, Gosselin JY (1983) Schizophrenia: A neurophysiological evaluation of abnormal information processing. Science 219(4586):874-876.
7. Wynn JK, Sugar C, Horan WP, Kern R, Green MF (2010) Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry 67(10):940-947.
8. van der Stelt O, Belger A (2007) Application of electroencephalography to the study of cognitive and brain functions in schizophrenia. Schizophr Bull 33(4):955-970.
9. Jahshan C, et al. (2012) Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. Bipolar Disord 14(3):239-248.
10. Sereno MI, Tootell RBH (2005) From monkeys to humans: What do we now know about brain homologies? Curr Opin Neurobiol 15(2):135-144.
11. Näätänen R, et al. (2011) The mismatch negativity: An index of cognitive decline in neuropsychiatric and neurological diseases and in ageing. Brain 134(Pt 12):3435-3453.
12. Pekkonen E, Jousmäki V, Reinikainen K, Partanen J (1995) Automatic auditory discrimination is impaired in Parkinson's disease. Electroencephalogr Clin Neurophysiol 95(1):47-52.
13. Vecchio F, Määttä S (2011) The use of auditory event-related potentials in Alzheimer's disease diagnosis. Int J Alzheimers Dis 2011:653173.
14. Garrido MI, Kilner JM, Stephan KE, Friston KJ (2009) The mismatch negativity: A review of underlying mechanisms. Clin Neurophysiol 120(3):453-463.
15. Javitt DC, Schroeder CE, Steinschneider M, Arezzo JC, Vaughan HG, Jr. (1992) Demonstration of mismatch negativity in the monkey. Electroencephalogr Clin Neurophysiol 83(1):87-90.
16. Woodman GF (2011) The Oxford Handbook of Event-Related Potential Components, eds Kappenman ES, Luck SJ (Oxford University Press, New York).
17. Polich J (2007) Updating P300: An integrative theory of P3a and P3b. Clin Neurophysiol 118(10):2128-2148.
18. Wieber J, Gugler R, Hengstmann JH, Dengler HJ (1975) Pharmacokinetics of ketamine in man. Anaesthesist 24(6):260-263.
19. Stoet G, Snyder LH (2006) Effects of the NMDA antagonist ketamine on task-switching performance: Evidence for specific impairments of executive control. Neuropsychopharmacology 31(8):1675-1681.
20. Taffe MA, Davis SA, Gutierrez T, Gold LH (2002) Ketamine impairs multiple cognitive domains in rhesus monkeys. Drug Alcohol Depend 68(2):175-187.
21. Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: A review. Schizophr Bull 2(1):19-76.
22. Goldberg TE, Weinberger DR (1996) Effects of neuroleptic medications on the cognition of patients with schizophrenia: A review of recent studies. J Clin Psychiatry 57(Suppl 9):62-65.
23. Foussias G, Remington G (2010) Antipsychotics and schizophrenia: From efficacy and effectiveness to clinical decision-making. Can J Psychiatry 55(3):117-125.
24. Korostenskaja M, Kähkönen S (2009) What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia? Curr Pharm Des 15(22): 2573-2593.
25. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF (1962) Model psychoses and schizophrenia. Am J Psychiatry 119:61-67.
26. Zukin SR, Zukin RS (1979) Specific [3H]phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76(10):5372-5376.
27. Kantrowitz JT, Javitt DC (2010) N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia? Brain Res Bull 83(3-4):108-121.
28. Swerdlow NR (2011) Are we studying and treating schizophrenia correctly? Schizophr Res 130(1-3):1-10.
29. Seeman P, Guan H-C (2008) Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia. Synapse 62(11):819-828.
30. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC (1996) Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: Implications for schizophrenia. Proc Natl Acad Sci USA 93(21):11962-11967.
31. Umbricht D, Koller R, Vollenweider FX, Schmid L (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51(5):400-406.
32. Kähkönen S, et al. (2002) Dopamine modulates involuntary attention shifting and reorienting: An electromagnetic study. Clin Neurophysiol 113(12):1894-1902.
33. Ueno A, et al. (2008) Auditory ERPs to stimulus deviance in an awake chimpanzee (Pan troglodytes): Towards hominid cognitive neurosciences. PLoS ONE 3(1):e1442.
34. Wylie GR, Clark EA, Butler PD, Javitt DC (2010) Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: Implications for pathophysiology of executive dysfunction in schizophrenia. Schizophr Bull 36(3):585-594.
35. Takahashi H, et al. (2012) Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses. Neuroimage 66C: 594-603.
36. Wacongne C, Changeux J-P, Dehaene S (2012) A neuronal model of predictive coding accounting for the mismatch negativity. J Neurosci 32(11):3665-3678.